1-9 of 9
Fengting Liu
Close
Sort by
Journal Articles

Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach

Timothy William Farren, Fengting Liu, Magali Le Garff-Tavernier, MD PhD, Marika Sarfati, Frans Nauwelaers, Jim Keenan, Noel Warner, Helene Merle-Beral, Samir G. Agrawal
Journal: Blood
Blood (2014) 124 (21): 1949.
https://doi.org/10.1182/blood.V124.21.1949.1949
Published: 2014
Journal Articles

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

Fengting Liu, MD Ph.D, Li Jia, PhD, MD, Ping Wang, MD, Tim Farren, PhD, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5305.
https://doi.org/10.1182/blood.V122.21.5305.5305
Published: 2013
Journal Articles

Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Samir G. Agrawal
Journal: Blood
Blood (2013) 122 (21): 4124.
https://doi.org/10.1182/blood.V122.21.4124.4124
Published: 2013
Journal Articles

Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Marion G. Macey, Ph.D, Thomas J. Kipps, MD, PhD, Noel Warner, Samir G. Agrawal
Journal: Blood
Blood (2013) 122 (21): 2572.
https://doi.org/10.1182/blood.V122.21.2572.2572
Published: 2013
Journal Articles

Drp1 Activation Overcomes Diffuse Large B-Cell Lymphoma Cells Radioresistance

Qingsong Pang, Sr., Ningbo Liu, Sr., Fengting Liu, Samir Agrawal, Ping Wang, Sr.
Journal: Blood
Blood (2012) 120 (21): 5121.
https://doi.org/10.1182/blood.V120.21.5121.5121
Published: 2012
Journal Articles

Early Detection of Minimal Residual Disease in Biological Prognostic Risk Groups in Chronic Lymphocytic Leukaemia (CLL) Utilizing the Novel CD160FCA Assay

Timothy W Farren, Fengting Liu, Marion Macey, Michael Jenner, MD, PhD, FRCPath, Samir Agrawal
Journal: Blood
Blood (2011) 118 (21): 2832.
https://doi.org/10.1182/blood.V118.21.2832.2832
Published: 2011
Journal Articles

Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells

Fengting Liu, Li Jia, MD, PhD, Timothy W Farren, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1784.
https://doi.org/10.1182/blood.V118.21.1784.1784
Published: 2011
Journal Articles

Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells

Fengting Liu, MD, PhD, Li Jia, MD, PhD, Timothy Farren, BSc(HONS), MIBMS, John G. Gribben, MD, DSc, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3598.
https://doi.org/10.1182/blood.V116.21.3598.3598
Published: 2010
Journal Articles

Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia – Evaluation of the Novel CD160FCA Assay

Timothy Farren, BSc(HONS), MIBMS, Fengting Liu, MD, PhD, Claire Stephens, MSc, Marion Macey, PhD, FRCPath, Michael Jenner, MD, PhD, FRCPath, Archie Prentice, MB, FRCP, FRCPath, Amit Nathwani, MBChB, FRCP, FRCPath, Samir Agrawal, MD, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 2723.
https://doi.org/10.1182/blood.V116.21.2723.2723
Published: 2010